MARKET WIRE NEWS

Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-05 16:58:45 ET

Iterum Therapeutics plc (ITRM)

Q2 2025 Earnings Conference Call

August 05, 2025 08:30 AM ET

Company Participants

Corey N. Fishman - President, CEO & Director

Judith M. Matthews - Chief Financial Officer

Kevin Dalton - Corporate Participant

Presentation

Operator

Good morning. Thank you for attending today's Iterum Therapeutics Second Quarter 2025 Financial Results and Business Update Call. My name is Megan, and I'll be your moderator for today. [Operator Instructions]...

Read the full article on Seeking Alpha

For further details see:

Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript
Iterum Therapeutics plc

NASDAQ: ITRM

ITRM Trading

1.0% G/L:

$0.1719 Last:

229,900 Volume:

$0.177 Open:

mwn-link-x Ad 300

ITRM Latest News

February 13, 2026 08:00:00 am
Iterum Therapeutics Provides Business Update

ITRM Stock Data

$15,988,461
51,778,499
0.46%
14
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 1

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App